[EXPERIMENTAL STUDIES ON THE THROMBOCYTOLYTIC SYSTEM. II. IS A HEMOLYTIC SERUM COMPLEMENT OR THE THROMBOCYTOLYTIC SERUM FACTOR NECESSARY FOR THE INCREASED LYSIS OF THROMBOCYTES BY AN ANTI-THROMBOCYTE SERUM?].
D000707:Anaphylaxis; D000818:Animals; D000937:Antigen-Antibody Reactions; D001779:Blood Coagulation Factors; D001792:Blood Platelets; D003165:Complement System Proteins; D004731:Endotoxins; D006168:Guinea Pigs; D006801:Humans; D006967:Hypersensitivity; D007106:Immune Sera; D011817:Rabbits; D012106:Research; D012769:Shock; D012772:Shock, Septic
D001779:Blood Coagulation Factors; D004731:Endotoxins; D007106:Immune Sera; D003165:Complement System Proteins
ANAPHYLAXIS; ANTIGEN-ANTIBODY REACTIONS; BLOOD COAGULATION FACTORS; BLOOD PLATELETS; COMPLEMENT; ENDOTOXINS; EXPERIMENTAL LAB STUDY; GUINEA PIGS; HYPERSENSITIVITY; IMMUNE SERUMS; RABBITS; SHOCK, TOXIC
EXPERIMENTELLE UNTERSUCHUNGEN UEBER DAS THROMBOZYTOLYTISCHE SYSTEM. II. IST HAEMOLYTISCHES SERUMKOMPLEMENT ODER DER THROMBOZYTOLYTISCHE SERUMFAKTOR FUER DIE GESTEIGERTE LYSE VON THROMBOZYTEN DURCH EIN ANTI-THROMBOZYTEN-SERUM ERFORDERLICH?